Sterne, Kessler, Goldstein & Fox published an article for Life Sciences IP Review by Director Paul Calvo examining how IP, data, and strategic assets influence biotech value creation and licensing.

Public source

Publisher name

Public post

Is Europe’s biotech challenge only about access to capital? In an article for Life Sciences IP Review, Director Paul Calvo argues that the bigger issue is who ultimately…

Log in to read the full post

Company

About Sterne, Kessler, Goldstein & Fox

Sterne, Kessler, Goldstein & Fox is a full-service intellectual property law firm that provides innovative solutions tailored to your business and industry. Since our founding in 1978, we have grown to become one of the largest IP specialty law firms in the United States. We collaborate across the full spectrum of IP to deliver real results for our clients—from patent and trademark prosecution, to patent litigation in federal district and appellate courts, strategic IP counseling, due diligence, and post-grant proceedings before the Patent Trial and Appeal Board. Our team includes attorneys, patent agents, and technical specialists with 100+ advanced degrees, including 60+ Ph.D.s,, in science and engineering disciplines. We work with the world’s leading innovators and brands, ranging from individual inventors and startups to renowned universities and Fortune 500 companies. We are proud to be one of the most highly regarded IP specialty law firms, and we have cultivated an environment that is welcoming, inclusive, and intellectually stimulating. And we’re honored that our attorneys and staff have voted Sterne Kessler as a Washington Post “Top Workplace” for 12 years running.

See more

Latest activity

40 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.